(Q33545117)

27 July 2017

1 reference

title

Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir (English)

1 reference

27 July 2017

1 reference

K C Cundy

1

1 reference

27 July 2017

publication date

1 February 1999

1 reference

Clinical Pharmacokinetics

27 July 2017

published in

1 reference

27 July 2017

volume

36

1 reference

27 July 2017

issue

2

1 reference

27 July 2017

page(s)

127-143

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199936020-00004

27 July 2017

exact match

0 references

cites work

Clinical pharmacokinetics of probenecid

1 reference

12 December 2020

Oral, subcutaneous, and intramuscular bioavailabilities of the antiviral nucleotide analog 9-(2-phosphonylmethoxyethyl) adenine in cynomolgus monkeys

1 reference

12 December 2020

Pharmacokinetics of cidofovir in monkeys. Evidence for a prolonged elimination phase representing phosphorylated drug

1 reference

12 December 2020

Synthesis, oral bioavailability determination, and in vitro evaluation of prodrugs of the antiviral agent 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).

1 reference

12 December 2020

Nursing considerations in the use of cidofovir for CMV retinitis in patients with AIDS: report of a roundtable meeting

1 reference

12 December 2020

Phosphorylation of 9-(2-phosphonomethoxyethyl)adenine and 9-(S)-(3-hydroxy-2-phosphonomethoxypropyl)adenine by AMP(dAMP) kinase from L1210 cells

1 reference

12 December 2020

(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue

1 reference

12 December 2020

(S)-1-(3-hydroxy-2-(phosphonylmethoxy)propyl)cytosine (HPMPC): a potent antiherpesvirus agent.

1 reference

12 December 2020

Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynomolgus monkeys.

1 reference

12 December 2020

Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Pharmacokinetics of stavudine in patients with AIDS or AIDS-related complex

1 reference

12 December 2020

Clinical experience with cidofovir in the treatment of cytomegalovirus retinitis

1 reference

12 December 2020

Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients

1 reference

12 December 2020

Bioavailability and metabolism of cidofovir following topical administration to rabbits

1 reference

12 December 2020

Successful use of cidofovir in treating AIDS-related cytomegalovirus retinitis, encephalitis, and esophagitis

1 reference

12 December 2020

Identification of enzymes catalyzing two-step phosphorylation of cidofovir and the effect of cytomegalovirus infection on their activities in host cells

1 reference

12 December 2020

Successful treatment of cytomegalovirus encephalitis in an AIDS patient using cidofovir

1 reference

12 December 2020

Recurrent iritis after intravenous administration of cidofovir

1 reference

12 December 2020

Effect of probenecid on the distribution, metabolism, and excretion of cidofovir in rabbits

1 reference

12 December 2020

Determination of 9-[(2-phosphonylmethoxy)ethyl]adenine in rat urine by high-performance liquid chromatography with fluorescence detection

1 reference

12 December 2020

5-Phosphoribosyl 1-pyrophosphate synthetase converts the acyclic nucleoside phosphonates 9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 9-(2-phosphonylmethoxyethyl)adenine directly to their antivirally active diphosphate derivatives

1 reference

12 December 2020

Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates

1 reference

12 December 2020

High-performance liquid chromatographic determination of cytosine-containing compounds by precolumn fluorescence derivatization with phenacyl bromide: application to antiviral nucleosides and nucleotides

1 reference

12 December 2020

Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial

1 reference

12 December 2020

9-(2-Phosphonylmethoxyethyl)adenine (PMEA) effectively inhibits retrovirus replication in vitro and simian immunodeficiency virus infection in rhesus monkeys

1 reference

12 December 2020

Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats

1 reference

12 December 2020

Cidofovir: a new therapy for cytomegalovirus retinitis

1 reference

12 December 2020

Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects

1 reference

12 December 2020

Treatment of adenoviral conjunctivitis with topical cidofovir

1 reference

12 December 2020

Isolation and identification of a metabolite of cidofovir from rat kidney

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS.

1 reference

12 December 2020

Biochemical pharmacology of acyclic nucleotide analogues

1 reference

12 December 2020

Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine

1 reference

12 December 2020

Anti-human immunodeficiency virus (HIV) activity, safety, and pharmacokinetics of adefovir dipivoxil (9-[2-(bis-pivaloyloxymethyl)-phosphonylmethoxyethyl]adenine) in HIV-infected patients

1 reference

12 December 2020

Oral bioavailability of the antiretroviral agent 9-(2-phosphonylmethoxyethyl)adenine (PMEA) from three formulations of the prodrug bis(pivaloyloxymethyl)-PMEA in fasted male cynomolgus monkeys

1 reference

12 December 2020

Pharmacokinetics and metabolism of selected prodrugs of PMEA in rats

1 reference

12 December 2020

Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients

1 reference

12 December 2020

Acyclic adenine nucleoside phosphonates in plasma determined by high-performance liquid chromatography with fluorescence detection

1 reference

12 December 2020

Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits

1 reference

12 December 2020

Pharmacokinetics in mice of the anti-retrovirus agent 9-(2-phosphonylmethoxyethyl)adenine

1 reference

12 December 2020

Oral formulations of adefovir dipivoxil: in vitro dissolution and in vivo bioavailability in dogs.

1 reference

12 December 2020

Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent

1 reference

12 December 2020

The use of probenecid as a chemoprotector against cisplatin nephrotoxicity

1 reference

12 December 2020

Optimization of in vitro flux through hairless mouse skin of cidofovir, a potent nucleotide analog

1 reference

12 December 2020

Relationship between the Transport and Toxicity of Cephalosporins in the Kidney

1 reference

12 December 2020

Treatment of acyclovir-resistant herpes simplex virus infections in patients with AIDS

1 reference

12 December 2020

10.2165/00003088-199936020-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

27 July 2017

1051828923

0 references

1 reference